Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1323645 PARIS, I0

Position in BMRN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$10,228,361
-$2,634,311 QoQ
Shares Held
181,065
-16.3% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Mar 31, 2026
CallValue
$796,509
CallShares
14,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. BMRN ranks #8 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 BMRN
Biomarin Pharmaceutical Inc
This page
181,065 $10,228,361

All Filings in BMRN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,228,361 181,065
2026-03-31 $796,509 14,100
2025-12-31 $814,191 13,700
2025-12-31 $12,862,672 216,434
2025-12-31 $2,650,578 44,600
2025-09-30 $3,547,480 65,500
2025-09-30 $5,177,696 95,600
2025-09-30 $11,623,873 214,621
2025-06-30 $4,644,965 84,500
2025-06-30 $4,337,133 78,900
2025-06-30 $10,542,531 191,787
2025-03-31 $6,291,410 89,000
2025-03-31 $3,202,681 45,306
2025-03-31 $4,340,366 61,400
2024-12-31 $6,172,047 93,900
2024-12-31 $3,848,294 58,547
2024-12-31 $6,921,369 105,300
2024-09-30 $1,546,380 22,000
2024-09-30 $10,606,479 150,896
2024-06-30 $2,682,064 32,577
2024-03-31 $3,502,246 40,099
2021-06-30 $1,585,360 19,000
2021-03-31 $823,059 10,900
2021-03-31 $868,365 11,500
2020-12-31 $2,429,013 27,700
2020-12-31 $2,507,934 28,600